eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2012
vol. 8
 
Share:
Share:
abstract:

Case report
Successful closure of a very large secundum atrial septal defect with the Occlutech Figulla® device

Abdurrahman Tasal
,
Ahmet Bacaksiz
,
Ercan Erdogan
,
Osman Sonmez

Postep Kardiol Inter 2012; 8, 4 (30): 347–350
Online publish date: 2012/11/26
View full text Get citation
 
Atrial septal defect (ASD) is one of the most common adult congenital heart diseases. It is characterized by a defect in the interatrial septum allowing pulmonary venous return from the left atrium to pass directly to the right atrium. It can result in pulmonary hypertension, congestive heart failure and cerebrovascular accident, so elective closure is recommended for all ASDs with evidence of right ventricular overload or with a clinically significant left-to-right shunt. Treatment methods include surgical and percutaneous closure. Transcatheter device closure is the method of choice in most centres nowadays. The rate of complications and length of hospital stay are lower compared to surgical closure. This technique can be performed successfully for a wide range of defects. Very large defects with inadequate rims could decrease the procedural success. The Occlutech Figulla ASD Flex Occluder is a new percutaneous closure device with some advantages such as higher flexibility, minimized amount of material implanted, and absence of the left atrial clamp in order to reduce trauma risk and clot formation on the left atrial disc. We think that these unique features could increase the procedural success rate. We report a patient with a very large defect who underwent transcatheter device closure using the Occlutech Figulla® device.
keywords:

atrial septal defect, transcatheter closure, Occlutech Figulla® device, adult congenital heart disease

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.